Rating History for Entasis Therapeutics (ETTX) by Alliance Global Partners

Date Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
3/16/2022 James Molloy Downgrade Neutral
(Buy)
N/A
(N/A)
1.86
(2.19)
17.74% Details